Company Filing History:
2 out of 448 
2 out of 3,539 
Years Active: 2013-2016
Title: Emyr Lloyd-Evans: Innovator in Substrate Reduction Therapy
Introduction
Emyr Lloyd-Evans is a notable inventor based in Oxford, GB. He has made significant contributions to the field of medical research, particularly in the area of substrate reduction therapy. With a total of 2 patents to his name, his work focuses on innovative treatments for complex diseases.
Latest Patents
Lloyd-Evans' latest patents include a groundbreaking invention that provides a compound which is an inhibitor of sphingolipid biosynthesis. This compound is intended for use in the treatment of diseases that exhibit a secondary Niemann-Pick type C disease-like cellular phenotype. His research aims to address critical health challenges through novel therapeutic approaches.
Career Highlights
Throughout his career, Emyr Lloyd-Evans has worked with prestigious organizations such as Oxford University Innovation Limited and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Lloyd-Evans has collaborated with esteemed colleagues, including Frances M Platt and Forbes Dennison Porter. These partnerships have enriched his research and fostered innovation in the field.
Conclusion
Emyr Lloyd-Evans stands out as a dedicated inventor whose work in substrate reduction therapy has the potential to transform treatment options for complex diseases. His contributions to medical research continue to inspire advancements in healthcare.